- NVDA remains a Wall Street favorite with a Strong Buy consensus and price targets around the mid-262s, signaling meaningful upside despite near-term risks.  
- The Groq licensing/acquisition move is boosting NVDA’s AI inference capabilities, with analysts like Arcuri (target around $270) and UBS/Citi positive on the potential to enhance real-time inference performance.  
- Near-term GPU supply dynamics (memory shortages) are pressuring consumer GPU pricing and shaping production plans, including a 30–40% cut in gaming-GPU output in H1 2026 and a restart of the RTX 3060 to maintain the lower end of the market.  
- NVDA is expanding its AI stack reach through collaborations (e.g., Arbe Robotics for autonomous driving) and by integrating Groq’s IP, reinforcing its moat in both training and inference.  
- The market outlook remains upbeat on NVDA driven by large-scale AI/data-center spending and CES 2026 visibility, underscoring a bullish sentiment for NVDA’s growth trajectory.  

Rating: 